AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 11:38 AM GMTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
Daiichi Sankyo gets Japenese nod for Tarlige tablets to treat neuropathic pain Ruchika Sharma31 March 2022 4:15 AM GMTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained approval in Japan to change the indication of the analgesic...
US Fund Emqore sues Fortis parent IHH for USD 6.5 billion Medical Dialogues Bureau11 Jan 2022 9:52 AM GMTNew Delhi: In a stock exchange filing last week, Malaysian healthcare group IHH Healthcare Berhad (IHH) said that US fund Emqore Envesecure Private...
Daiichi Sankyo submits NDA for Lymphoma treatment Valemetostat in Japan Ananya Shrivastava2 Jan 2022 5:15 AM GMTTokyo: Daiichi Sankyo Company, Limited has announced that it has submitted a New Drug Application (NDA) to Japan's Ministry of Health, Labour and...
Daiichi Sankyo gets approval for additional indication of Antiplatelet Agent Efient in Japan Ruchika Sharma27 Dec 2021 12:08 PM GMTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained a supplemental new drug application approval for additional...
SC asks Fortis to submit details of Rs 4000 crores IHH deal, Singh brothers role by March 1 MD Bureau26 Feb 2021 4:00 AM GMTNew Delhi: In the latest update regarding the Fortis Healthcare Row, the Supreme Court of India, on Wednesday, has asked the company to provide the...
Daiichi Sankyo names Ken Takeshita as Global Head of RnD Ruchika Sharma24 Feb 2021 9:18 AM GMTTokyo & Munich & Basking Ridge, N.J.: Daiichi Sankyo Company, Limited has recently announced Ken Takeshita, MD will be named the new Global...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sep 2020 3:45 AM GMTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
Daiichi Sankyo Plea: Delhi HC issues notice to Singh Brothers, next hearing on July 28 Farhat Nasim25 Jun 2020 11:43 AM GMTDaiichi's counsel senior advocate Arvind Nigam contended that as per an affidavit filed by the respondent the mark is essential. It was submitted that...
SETBACK: Singapore SC junks Singh Brothers plea against Rs 3500 crore arbitral award in Daiichi Case Farhat Nasim1 Jun 2020 6:26 AM GMTNew Delhi: In a major setback to Singh Brothers, the Singapore Court of Appeals on May 28 junked the petition filed by the former Ranbaxy promoters,...
Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer Ruchika Sharma26 May 2020 7:23 AM GMTTokyo, Munich: Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate...
AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu Ruchika Sharma25 May 2020 6:26 AM GMTUS: Daiichi Sankyo Company Limited and AstraZeneca's Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the...
